Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chitosan oligosaccharide composite solid beverage assisting in treatment of type 2 diabetes

A type 2 diabetes and solid beverage technology, applied in the field of chitosan oligosaccharide composite solid beverage, can solve problems such as organ damage or gastrointestinal dysfunction, and achieve the goals of promoting growth and colonization, reducing relative abundance, and promoting intestinal health Effect

Pending Publication Date: 2020-02-11
广州优蓝海洋生物科技有限公司 +1
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these available antidiabetic drugs still have adverse reactions such as some organ damage or gastrointestinal dysfunction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chitosan oligosaccharide composite solid beverage assisting in treatment of type 2 diabetes
  • Chitosan oligosaccharide composite solid beverage assisting in treatment of type 2 diabetes
  • Chitosan oligosaccharide composite solid beverage assisting in treatment of type 2 diabetes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0029] Components of chitosan Example 1 Example 2 Example 3 Example 4 Oligochitosan 5％ 30％ 28％ 26％ stachyose 17％ 2％ 18％ 15％ Oat beta-glucan 20％ 20％ 18％ 5％ White Kidney Bean Extract 38％ 38％ 16％ 36％ Linseed Oil Microcapsules Powder 20％ 10％ 20％ 18％

experiment example

[0031] In order to further illustrate the effect, take embodiment 3 as an example to carry out the experiment, and the specific experimental conditions are as follows:

[0032] 1. Experimental materials and instruments

[0033] The chitosan used in the experiment is as the standard in Example 3; 4 weeks old (body weight 18~22g) healthy male clean level Kunming mice [production license: SCXK (army) 2007-004, certificate number: 00549571] and high Lipid feed and basal feed were purchased from the Experimental Animal Center of the Academy of Military Medical Sciences of the Chinese People's Liberation Army; acarbose tablets (Acar) Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; total cholesterol (TC), triglyceride (TG), Cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT) kits were purchased from Nanjing Jiancheng Bioengineering Institute; AxyPrepDNA Gel Extraction Kit was purchased from AXYGEN Com...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a chitosan oligosaccharide composite solid beverage assisting in treatment of type 2 diabetes. The chitosan oligosaccharide composite solid beverage comprises the following components in percentage by weight of 5-30% of chitosan oligosaccharide, 2-18% of stachyose, 5-20% of oat beta-glucan, 16-38% of a navy bean extract and 10-20% of linseed oil microcapsule powder. The chitosan oligosaccharide composite solid beverage has the effects of assisting in reducing blood lipid and stabilizing blood sugar, and besides, the solid beverage can improve intestinal flora, improvethe immunity of intestinal tracts and assist in treatment of the type 2 diabetes.

Description

technical field [0001] The invention relates to the technical field of health care products, in particular to a chitosan oligosaccharide composite solid drink for assisting the treatment of type II diabetes. Background technique [0002] Type 2 diabetes (Type 2diabetes, T2DM) is one of the metabolic disorders characterized by hyperglycemia (often accompanied by symptoms of hyperlipidemia), often accompanied by various chronic complications such as neuropathy, kidney disease, and cardiovascular and cerebrovascular diseases. Symptoms occur. It can lead to multi-organ and multi-system damage and disability, with a high fatality rate. It is a major threat to public health. According to estimates by the International Diabetes Federation, there were 415 million diabetics in the world in 2015, and this number is expected to increase to 592 million by 2035. Diabetics in my country far exceed other countries, and the number is still continue to increase. Therefore, my country is fa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A23L2/39A23L33/21A23L33/105A23L33/115
CPCA23L2/39A23L33/105A23L33/115A23L33/21A23V2002/00A23V2200/328A23V2200/3202A23V2200/324A23V2250/18A23V2250/21A23V2250/284A23V2250/632A23V2250/5034
Inventor 陈列欢罗学刚姜雅杰
Owner 广州优蓝海洋生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com